E&C Convenes Hearing on Health Care/AI
Summary
On September 3, 2025, the House Energy and Commerce (E&C) Committee’s Health Subcommittee held a hearing on “Examining Opportunities to Advance American Health Care through the Use of Artificial Intelligence Technologies.” The hearing featured testimony from TJ Parker, Lead Investor of General Medicine; Andrew Toy, CEO of Clover Health; Dr. Andrew Ibrahim, MD, MSc, Chief Clinical Officer at Viz.ai; Dr. Michelle Mello, JD, PhD, MPhil, Professor at Stanford Law School and Stanford University School of Medicine; and Dr. C. Vaile Wright, PhD, Senior Director, Health Care Innovation at the American Psychological Association (APA). Click here to read the full summary of the hearing.
Impacted Sectors
© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.